Ascend Therapeutics is a biopharmaceutical company, develops and commercializes pharmaceutical transdermal therapies for the treatment of chronic health conditions in the United States. Its products include afimoxifene gel, an antiestrogen for the treatment of cyclic breast pain and other estrogen dependent disorders in premenopausal women. It also offers transdermal dihydrotestosterone gel therapy for late-onset hypogonadism. The company was incorporated in 2001 and is headquartered in Herndon, Virginia.